Application of Adjuvant Chemotherapy in Colorectal Cancer – a Survey in the Region of Essen, Germany
Michael Ståhl(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), H. Wilke(Kliniken Essen-Mitte), Wolf Köster(Kliniken Essen-Mitte), Krista Schweers(Kliniken Essen-Mitte), Christian Müller(Medical University of Vienna)
Cited by 2
Related Papers
Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis
|Genes & Development|2009|351
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2020|202
Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib
|Radiology|2012|197
Sch9 regulates ribosome biogenesis via Stb3, Dot6 and Tod6 and the histone deacetylase complex RPD3L
|The EMBO Journal|2011|179